Search
Menu
Home
HTB
2017
August
01
1 August 2017
Contents
Hepatitis coinfection
FDA approves sofosbuvir/velpatasvir/voxilaprevir (Vosevi) second-line DAA HCV treatment in the US in the US
HTB RSS
Early access
13th IAS Conference on HIV Science (IAS 2025)
3 July 2025
UK HIV care for transgender and non-binary people: EHRC guidelines are unworkable
1 July 2025
Kigali Call to Action: sign-on for IAS 2025 conference
1 July 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
Why the new HIV PrEP guidelines from the UK are so exciting
2 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate
